These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 25442041

  • 1. [(18)F]FDG-PET standard uptake value as a metabolic predictor of bone marrow response to radiation: impact on acute and late hematological toxicity in cervical cancer patients treated with chemoradiation therapy.
    Elicin O, Callaway S, Prior JO, Bourhis J, Ozsahin M, Herrera FG.
    Int J Radiat Oncol Biol Phys; 2014 Dec 01; 90(5):1099-107. PubMed ID: 25442041
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients.
    Franco P, Arcadipane F, Ragona R, Lesca A, Gallio E, Mistrangelo M, Cassoni P, Arena V, Bustreo S, Faletti R, Rondi N, Morino M, Ricardi U.
    Med Oncol; 2016 Jul 01; 33(7):72. PubMed ID: 27277756
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Correlations Between Radiation Dose in Bone Marrow and Hematological Toxicity in Patients With Cervical Cancer: A Comparison of 3DCRT, IMRT, and RapidARC.
    Chang Y, Yang ZY, Li GL, Li Q, Yang Q, Fan JQ, Zhao YC, Song YQ, Wu G.
    Int J Gynecol Cancer; 2016 May 01; 26(4):770-6. PubMed ID: 26844613
    [Abstract] [Full Text] [Related]

  • 9. Dose-volume parameters of MRI-based active bone marrow predict hematologic toxicity of chemoradiotherapy for rectal cancer.
    Kuncman Ł, Stawiski K, Masłowski M, Kucharz J, Fijuth J.
    Strahlenther Onkol; 2020 Nov 01; 196(11):998-1005. PubMed ID: 32621010
    [Abstract] [Full Text] [Related]

  • 10. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM, Chang T, Graham MM, Marquardt MD, Button A, Smith BJ, Menda Y, Sun W, Pagedar NA, Buatti JM.
    Int J Radiat Oncol Biol Phys; 2015 Mar 01; 91(3):472-9. PubMed ID: 25680593
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Changes in cervical cancer FDG uptake during chemoradiation and association with response.
    Kidd EA, Thomas M, Siegel BA, Dehdashti F, Grigsby PW.
    Int J Radiat Oncol Biol Phys; 2013 Jan 01; 85(1):116-22. PubMed ID: 22520475
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prognostic Value of Fluorine-18 Fluorodeoxyglucose Uptake of Bone Marrow on Positron Emission Tomography/Computed Tomography for Prediction of Disease Progression in Cervical Cancer.
    Lee JW, Jeon S, Mun ST, Lee SM.
    Int J Gynecol Cancer; 2017 May 01; 27(4):776-783. PubMed ID: 28333846
    [Abstract] [Full Text] [Related]

  • 15. Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy.
    Noticewala SS, Li N, Williamson CW, Hoh CK, Shen H, McHale MT, Saenz CC, Einck J, Plaxe S, Vaida F, Yashar CM, Mell LK.
    Int J Radiat Oncol Biol Phys; 2017 Mar 15; 97(4):797-805. PubMed ID: 28244416
    [Abstract] [Full Text] [Related]

  • 16. Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy.
    Tan S, Kligerman S, Chen W, Lu M, Kim G, Feigenberg S, D'Souza WD, Suntharalingam M, Lu W.
    Int J Radiat Oncol Biol Phys; 2013 Apr 01; 85(5):1375-82. PubMed ID: 23219566
    [Abstract] [Full Text] [Related]

  • 17. Incorporating 18FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation.
    Franco P, Fiandra C, Arcadipane F, Trino E, Giglioli FR, Ragona R, Ricardi U.
    BMC Cancer; 2017 Nov 02; 17(1):710. PubMed ID: 29096619
    [Abstract] [Full Text] [Related]

  • 18. Association between bone marrow dosimetric parameters and acute hematologic toxicity in cervical cancer patients undergoing concurrent chemoradiotherapy: comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy.
    Hui B, Zhang Y, Shi F, Wang J, Wang T, Wang J, Yuan W, Li Y, Liu Z.
    Int J Gynecol Cancer; 2014 Nov 02; 24(9):1648-52. PubMed ID: 25275663
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.
    Teo BK, Badiee S, Hadi M, Lam T, Johnson L, Seo Y, Bacharach SL, Hasegawa BH, Franc BL.
    Nucl Med Commun; 2008 Apr 02; 29(4):359-66. PubMed ID: 18317301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.